NCT04150614View on ClinicalTrials.gov

BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Chemotherapy-induced Nausea and Vomiting
Interventions
DRUG

Granisetron Transdermal Patch

Antiemetic

DRUG

Intravenous Dexamethasone

Antiemetic

DRUG

Ondansetron

ondansetron

Trial Locations (1)

60612

RECRUITING

University of Illinois Cancer Center, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER